STAGING DESIGN PROTOTYPE / SYNTHETIC DATA / NOT A LIVE SCREENSHOT - NO PAYMENTS PROCESSED - TEST-001 ONLY - Prototype reference date: 01 OCT 2026 - SCREEN 05/10 CHECKOUT - meelomd.com/checkout/ - FIXED FOR LEGITSCRIPT RED - Prototype reference date: 01 OCT 2026

1 ORDER SUMMARY & TEMPORARY HOLD - DEMO ORDER TEST-001 (Synthetic)

COMPOUNDED TIRZEPATIDE 90-day bundle: $649 - Compounded medication - Not FDA-approved

No add-ons selected yet - B12/C requires provider approval - Price TBD - Requires pharmacy confirmation

TOTAL TODAY: $649 (bundle only) - Shown for staging

COMPOUNDED MEDICATIONS ARE NOT FDA-APPROVED and are offered only where legally permitted. No claim that compounded products are generic versions or the same as FDA-approved drugs. No claim that compounded drugs use the same active ingredient as FDA-approved drugs or that compounded drugs are clinically proven to produce results for the patient.

Checkbox 1 REQUIRED - Must be checked to proceed: I authorize a temporary hold of $649. This is NOT payment for medication. This hold reserves my bundle pending clinical review. I understand no medication will be dispensed without a prescription issued by a licensed provider in TelegraMD network.

2 CONDITIONAL $39 FEE ACKNOWLEDGEMENT - REQUIRED DISCLOSURE

The $39 consultation / missed-visit fee applies ONLY if:

(a) you do not complete your clinical intake within 72h, OR
(b) provider determines no prescription is appropriate after review, OR
(c) you cancel after provider review but before pharmacy release.

This fee does NOT apply if a prescription is issued and you approve purchase.

Checkbox 2 REQUIRED: I acknowledge the conditional $39 fee triggers above. I understand this is separate from medication cost.

3 AFTER PRESCRIPTION - SECOND APPROVAL REQUIRED BEFORE PHARMACY RELEASE - LOCKED IN PROTOTYPE - Shown for LegitScript review

Your prescribed plan: To be determined by provider after review

Approved add-ons: To be determined - e.g., B12 injectable - Price TBD - requires pharmacy confirmation

Exact total: To be calculated after prescription - You must explicitly approve before any charge - No automatic payment.

Checkbox 3 Disabled in prototype - Shows concept: I have reviewed my prescribed plan, approved add-ons, and exact total of $____ and authorize payment and pharmacy release to TelegraMD's pharmacy network.

Review note: Current UI concept. No payment processed. No pharmacy release in prototype. Second approval flow requires TelegraMD integration. Static design only.

WHO DOES WHAT - Relationship Clarification - Q22/Q23/Q33

Meelo Health Inc.: Provides website, checkout UI concept (this page), nonclinical myMeelo AI support. Does NOT have pharmacy partnership. Does NOT dispense or determine dose.

TelegraMD: Performs clinical intake review, determines if prescription appropriate, determines dose/schedule, approves add-ons, holds ALL pharmacy relationships (including Hallandale Pharmacy network and Boudreaux's Specialty Compounding if applicable), transmits patient-specific prescription to licensed 503A/503B pharmacy in its network for dispensing.

Pharmacy: Licensed 503A/503B pharmacy in TelegraMD network dispenses and ships - e.g., Hallandale Pharmacy - final pharmacy TBD pending verification - No direct Meelo affiliation. If Boudreaux's Specialty Compounding (boudreauxscompounding.com) is not LegitScript certified, TelegraMD will transition to certified pharmacy - Meelo does NOT intend to keep non-certified partnership if barrier.